Recombinant Alkaline Phosphatase Purification for Metal Ion Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for producing recombinant alkaline phosphatases, such as asfotase alfa, face challenges in maintaining and enhancing enzymatic activity due to the disruptive effects of certain metal ions like Nickel, Cobalt, Copper, and Manganese, leading to suboptimal therapeutic efficacy in conditions like hypophosphatasia.
Innovation Solution
A method is developed to produce recombinant alkaline phosphatases by minimizing the concentration of disruptive metal ions (Ni, Co, Cu, Mn) and increasing the concentration of stabilizing ions (Zn, Si) through specific steps like Hydrophobic Interaction Chromatography (HIC) and buffer adjustments, thereby enhancing enzyme stability and activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If metal ions (Ni, Co, Cu, Mn) are present in the preparation, then the production process is simpler, but the enzymatic activity of alkaline phosphatase decreases
Solution Approach 1:
The patent applies preliminary action by adjusting metal ion concentrations in the culture medium before cell culture to optimize enzymatic activity. Specifically, the culture medium contains controlled concentrations of Zn2+ (5-50 μM), Mg2+ (0.1-1 mM), and limited concentrations of disruptive ions (Ni2+ <1 μM, Co2+ <0.1 μM, Cu2+ <10 μM, Mn2+ <0.5 μM). This pre-optimization of metal ion composition before production ensures high specific activity of the recombinant alkaline phosphatase while simplifying downstream purification.
Solution Approach 2:
The patent applies parameter changes by systematically optimizing metal ion concentrations in the culture medium and processing solutions. The method specifies precise concentration ranges: Zn2+ (5-50 μM), Mg2+ (0.1-1 mM), Ca2+ (0.1-1 mM), and strict limits on disruptive ions (Ni2+ <1 μM, Co2+ <0.1 μM, Cu2+ <10 μM, Mn2+ <0.5 μM). These parameter optimizations directly enhance enzymatic activity and stabilize the protein structure during production and purification.
2Reliability
If high concentrations of disruptive metal ions are used, then the production cost is lower, but the therapeutic efficacy decreases
Solution Approach 1:
The patent applies parameter changes by establishing specific concentration thresholds for metal ions to ensure therapeutic efficacy. The culture medium and processing solutions maintain Zn2+ at 5-50 μM and Mg2+ at 0.1-1 mM, while strictly limiting disruptive ions (Ni2+ <1 μM, Co2+ <0.1 μM, Cu2+ <10 μM, Mn2+ <0.5 μM). These optimized parameters produce recombinant alkaline phosphatase with high specific activity suitable for treating hypophosphatasia.
Solution Approach 2:
The patent uses zinc ions as an intermediary element that protects against the harmful effects of disruptive metal ions. Zn2+ (at 5-50 μM) competes with disruptive ions for binding sites on the alkaline phosphatase enzyme, preventing Ni2+, Co2+, Cu2+, and Mn2+ from interfering with enzymatic activity. This intermediary approach ensures therapeutic efficacy while allowing for practical production.
3Stability of the object's composition
If metal ion concentrations are not controlled, then the manufacturing process is simpler, but the enzyme stability decreases
Solution Approach 1:
The patent applies preliminary action by pre-formulating the culture medium and processing solutions with optimized metal ion compositions. The medium contains Zn2+ (5-50 μM), Mg2+ (0.1-1 mM), and Ca2+ (0.1-1 mM) from the beginning, with disruptive ions strictly limited (Ni2+ <1 μM, Co2+ <0.1 μM, Cu2+ <10 μM, Mn2+ <0.5 μM). This preliminary optimization ensures enzyme stability throughout the production and purification process without requiring complex post-production adjustments.
Solution Approach 2:
The patent applies parameter changes by controlling metal ion concentrations at critical stages: culture medium composition, harvest buffer, and purification buffers. The method specifies Zn2+ (5-50 μM), Mg2+ (0.1-1 mM), and strict limits on disruptive ions throughout the process. These parameter controls maintain enzyme stability while keeping the manufacturing process practical and scalable.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method significantly increases the specific activity of alkaline phosphatases, making them more effective for therapeutic applications by reducing disruptive metal ion interference and stabilizing the enzyme with zinc ions, thus improving treatment outcomes.
Implementation Method 1
separating the recombinant alkaline phosphatase from the remainder of the preparation by Hydrophobic Interaction Chromatography (HIC)
Data Source
Figure 1
Figure 2A~2C
Figure 3A~3C
AI summary
The disclosure provides a method of producing recombinant alkaline phosphatase comprising: (i) culturing an alkaline phosphatase in a recombinant cell culture; (ii) obtaining a preparation of recombinant alkaline phosphatase from the cell culture; and (iii) minimizing in the preparation a concentration of at least one metal ion selected from the group consisting of: Nickel (Ni), Cobalt (Co), Copper (Cu), Manganese (Mn), Chromium (Cr), and Molybdenum (Mo).